Acute	acute	acut
respiratory	respiratory	respiratori
distress	distress	distress
syndrome	syndrome	syndrom
(ARDS)	(ards)	(ards)
and	and	and
acute	acute	acut
lung	lung	lung
injury	injury	injuri
(ALI)	(ali)	(ali)
are	are	are
conditions	conditions	condit
associated	associated	associ
with	with	with
an	an	an
estimated	estimated	estim
mortality	mortality	mortal
of	of	of
40–50%	40–50%	40–50%
.	.	.
The	the	the
use	use	use
of	of	of
inhaled	inhaled	inhal
vasodilators	vasodilators	vasodil
can	can	can
help	help	help
to	to	to
improve	improve	improv
oxygenation	oxygenation	oxygen
without	without	without
hemodynamic	hemodynamic	hemodynam
effects	effects	effect
.	.	.
This	this	this
article	article	articl
reviews	reviews	review
relevant	relevant	relev
studies	studies	studi
addressing	addressing	address
the	the	the
safety	safety	safeti
and	and	and
efficacy	efficacy	efficaci
of	of	of
inhaled	inhaled	inhal
nitric	nitric	nitric
oxide	oxide	oxid
(iNO)	(ino)	(ino)
and	and	and
aerosolized	aerosolized	aerosol
epoprostenol	epoprostenol	epoprostenol
(aEPO)	(aepo)	(aepo)
in	in	in
the	the	the
treatment	treatment	treatment
of	of	of
life-threatening	life-threatening	life-threaten
hypoxemia	hypoxemia	hypoxemia
associated	associated	associ
with	with	with
ARDS	ards	ard
and	and	and
ALI	ali	ali
.	.	.
In	in	in
addition	addition	addit
,	,	,
the	the	the
article	article	articl
also	also	also
provides	provides	provid
a	a	a
practicable	practicable	practic
guide	guide	guid
to	to	to
the	the	the
clinical	clinical	clinic
application	application	applic
of	of	of
these	these	these
therapies	therapies	therapi
.	.	.
Nine	nine	nine
prospective	prospective	prospect
randomized	randomized	random
controlled	controlled	control
trials	trials	trial
were	were	were
included	included	includ
for	for	for
iNO	ino	ino
reporting	reporting	report
on	on	on
changes	changes	chang
in	in	in
oxygenation	oxygenation	oxygen
or	or	or
clinical	clinical	clinic
outcomes	outcomes	outcom
.	.	.
Seven	seven	seven
reports	reports	report
of	of	of
aEPO	aepo	aepo
were	were	were
examined	examined	examin
for	for	for
changes	changes	chang
in	in	in
oxygenation	oxygenation	oxygen
.	.	.
Based	based	base
on	on	on
currently	currently	current
available	available	avail
data	data	data
,	,	,
the	the	the
use	use	use
of	of	of
either	either	either
iNO	ino	ino
or	or	or
aEPO	aepo	aepo
is	is	is
safe	safe	safe
to	to	to
use	use	use
in	in	in
patients	patients	patient
with	with	with
ALI	ali	ali
or	or	or
ARDS	ards	ard
to	to	to
transiently	transiently	transient
improve	improve	improv
oxygenation	oxygenation	oxygen
.	.	.
No	no	no
differences	differences	differ
have	have	have
been	been	been
observed	observed	observ
in	in	in
survival	survival	surviv
,	,	,
ventilator-free	ventilator-free	ventilator-fre
days	days	day
,	,	,
or	or	or
attenuation	attenuation	attenu
in	in	in
disease	disease	diseas
severity	severity	sever
.	.	.
Further	further	further
studies	studies	studi
with	with	with
consistent	consistent	consist
end	end	end
points	points	point
using	using	use
standard	standard	standard
delivery	delivery	deliveri
devices	devices	devic
and	and	and
standard	standard	standard
modes	modes	mode
of	of	of
mechanical	mechanical	mechan
ventilation	ventilation	ventil
are	are	are
needed	needed	need
to	to	to
determine	determine	determin
the	the	the
overall	overall	overal
benefit	benefit	benefit
with	with	with
iNO	ino	ino
or	or	or
aEPO	aepo	aepo
.	.	.
